- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 211/76 - Oxygen atoms attached in position 2 or 6
Patent holdings for IPC class C07D 211/76
Total number of patents in this class: 270
10-year publication summary
|
15
|
26
|
24
|
25
|
15
|
21
|
20
|
21
|
13
|
4
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 3779 |
19 |
| Bristol-myers Squibb Company | 5080 |
10 |
| California Institute of Technology | 3884 |
9 |
| Takeda Pharmaceutical Company Limited | 2961 |
9 |
| Codexis, Inc. | 776 |
6 |
| The Scripps Research Institute | 1364 |
6 |
| Arvinas Operations, Inc. | 165 |
6 |
| BASF SE | 19740 |
5 |
| InterMune, Inc. | 97 |
5 |
| Cambridge Enterprise Limited | 1096 |
4 |
| Emory University | 1498 |
4 |
| Institut Univ. de Ciencia i Tecnologia, S.A. | 23 |
4 |
| Queen's University at Kingston | 517 |
4 |
| Janssen Pharmaceutica N.V. | 3839 |
3 |
| Merck Patent GmbH | 5909 |
3 |
| Abbott Laboratories | 2542 |
3 |
| Allergan, Inc. | 2600 |
3 |
| Board of Trustees of Michigan State University | 1141 |
3 |
| ChemoCentryx, Inc. | 400 |
3 |
| Eli Lilly and Company | 3645 |
3 |
| Other owners | 158 |